and Hanau (1960) described a tuberculin-like response to the intradermal injection of autologous and homologous leucocytes in patients with SLE and, less frequently, rheumatoid arthritis. Subsequent workers (Tromovitch and March, 1961; Bennett and Holley, 1961; Azoury, Jones, Derbes, and Gum, 1966) have confirmed this cutaneous hypersensitivity to leucocytes in the majority of patients with SLE; furthermore, a similar dermal response has been demonstrated after challenge with heterologous nuclear antigens, especially calf thymus deoxyribonucleic acid (DNA) (Azoury and others, 1966; Ores and Lange, 1964; Chieregato and Faldarini, 1964; Fardal and Winkelmann, 1965 erythematosus or with rheumatoid arthritis and controls were challenged with a battery of bacterial and fungal antigens and calf thymus DNA. No evidence for heightened delayed hypersensitivity in patients with SLE was found, even with respect to DNA. In fact, patients with systemic lupus demonstrated a significant hyporeactivity to intermediate strength PPD (purified protein derivative (tuberculin)) which, although unexplained, is of practical significance in the management of patients with this disease.
Material and Methods
Patients.-Twenty patients with SLE and 23 with definite or classical rheumatoid arthritis were obtained from the Connective Tissue Disease and Arthritis Clinics and the in-patient medical service of the Johns Hopkins Hospital. Selection was based solely upon certainty of clinical diagnosis and the patients' cooperation and availability for study. All were women. 112 controls were obtained from among female patients hospitalized on the medical service. Specifically excluded from the control group were patients with definite or suspect connective tissue disease, patients with tuberculosis, and potentially anergic individuals such as those with sarcoidosis, Hodgkin's disease, or patients receiving cytotoxic drug therapy.
Skin Test
Procedure.-Patients were tested with the following battery of six antigens:
(1) Intermediate strength PPD,* 0-0001 mg. per 0-1 ml.;
(2) Histoplasmin,* 1 :100 dilution; (3) Trichophytin, ** 1:30 dilution;
(4) Candida albicans extract,** 1:100 dilution; (5) Streptokinase (SK)-Streptodomase (SD),*** 10 units SK and 2-5 units SD per 0 1 ml; (6) Calf thymus DNA,**** 0-1 mg. per 0-1 ml., after the method of Ores and Lange (1964 Three factors, independent of the diagnosis of SLE, remained to be evaluated in relation to cutaneous reactivity, namely, (1) circulating antinuclear antibody, (2) corticosteroid therapy, and (3) age.
Serum Antinuclear Factors (ANF).-No positive correlation could be found between the presence of antinuclear factors in serum and the response to intradermal DNA (Table V) . Of the four SLE (Friou, 1952; Kirkpatrick, Wilson, and Talmage, 1964; Kelly, Good, and Varco, 1958 Abernathy, and Campbell, 1961) , and in Tecumseh, Michigan (Dodge, Payne, Whitehouse, and Bauman, 1965) . If one selects from the data of Peck and others (1961) the observations on women over the age of 14 years, 436 of 1,569 women (28 per cent.) had positive tests as defined by five or more millimetres of induration. Similarly, Dodge and others (1965) found positive reactions in 56 of the 221 women (25 per cent.) over the age of 20 years.
As yet, we have no satisfactory explanation for the observed anergy to PPD in our patients with systemic lupus. Host factors, such as age and race, which are known to influence response to tuberculin, would not appear to differ sufficiently from controls to provide an adequate explanation. Known exposure to tuberculosis was as frequent in those with SLE as among patients with other disorders. None of the patients with systemic lupus was uraemic or otherwise debilitated and none was receiving immunosuppressive levels of corticosteroid therapy. Moreover, the hyporeactivity in SLE patients was selective for PPD which argues strongly against a basic alteration in host capacity to manifest delayed hypersensitivity and suggests the possibility of altered immunity to mycobacteria. Of interest in this regard is the high incidence of tuberculosis found among the patients with systemic lupus reported by Harvey, Shulman, Tumulty, Conley, and Schoenrich (1954) from this hospital. Of their 38 autopsied patients, death was attributable to SLE in 22, one of whom was unexpectedly found at autopsy to have miliary tuberculosis. Moreover, "extensive tuberculosis" was the immediate cause of death in five additional patients, only one of whom have received corticosteroid therapy. Furthermore, subsequent experience in this hospital differs from 315 that of Dubois (1966) , who regards tuberculosis as "an unusual complication" in patients with SLE. In view of the practical clinical importance, as well as the theoretical implications, of tuberculin anergy in systemic lupus, further studies are in progress to define more clearly responsiveness to mycobacterial antigens.
Hypersensitivity to DNA.-Ores and Lange (1964) first described cutaneous hypersensitivity to intradermal calf-thymus DNA in all nineteen patients with SLE receiving the antigen. None of the 23 control patients demonstrated a positive response, defined by the authors as an area of induration equal in size to the original injection bleb. It was felt by these workers that the response to intradermal DNA offered a highly sensitive and equally specific diagnostic test for SLE. With more rigorous definition of a positive test in subsequent studies (Azoury and others, 1966; Ores and Lange, 1964; Chieregato and Faldarini, 1964; Fardal and Winkelmann, 1965) , fewer than half the patients with systemic lupus have been found to have a positive reaction.
Only four (20 per cent.) of our patients with SLE developed five or more millimetres of induration in response to DNA; the maximal response was 10 millimetres, found in one individual. Moreover, the same degree of reactivity with respect to both frequency of positive reactors and intensity of response was present in those with rheumatoid arthritis and in controls. This lack of specificity was also found by Fardal and Winkelmann (1965) Hypersensibilidad tardia en el lupus eritematoso diseminado SUMARIO Se ejecut6 una serie de reacciones cutaneas con antigenos bacteriales y mic6ticos y con el acido deoxiribonucleico (ADN) heter6logo en 20 enfermos con lupus eritematoso diseminado (SLE="systemic lupus erythematosus"), 23 enfermos con poliartritis reumatoide y en 112 testigos hospitalizados.
No se encontr6 diferencia alguno entre los tres grupos clinicos respecto a la frecuencia y la intensidad de las reacciones positivas hacia estos antigenos, con la excepcion de una hiporeactividad significativa hacia la tuberculina (PPD) en enfermos con SLE.
S6lo un 20 por ciento de los enfermos con SLE acusaron reacciones positivas hacia el ADN del timo de ternero intradermico. Esta proporci6n de reacciones positivas fue similar en los enfermos con poliartritis reumatoide (22 por ciento) y en los testigos (18 por ciento). Ademas, no se pudo establecer correlaci6n alguna entre la reactividad hacia el ADN en el SLE y cualquier otro rasgo clinico o serologico de esta enfermedad.
